Description     Claims  

WO2009076404A   [0008] 
WO2008045564A   [0008] 
US4447441A1   [0098] 

CXCL12/CXCR4/CXCR7 Chemokine Axis and Cancer Progression   [0004] 
The role of CXCR7/RDC1 as a chemokine Receptor for CXCL12/SDF-1 in prostate cancer   [0005] 
The effect of the CXCR7 inhibitor CCX662 on survival in the ENU rat model of gliobastoma   [0005] 
Chemokine receptor CXCR7 regulates the invasion, angiogenesis and tumor growth of human hepatocellular carcinoma cells   [0005] 
CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor associated vasculature   [0005] 
A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development   [0005] 
CXCR7 influences leukocyte entry into the CNS parenchyma by controlling abluminal CXCL12 abundance during autoimmunity   [0005] 
Antagonism of CXCR7 attenuates chronic hypoxia-induced pulmonary hypertension   [0005] 
Pathogenic role of CXCR7 in rheumatoid arthritis   [0005] 
CXCL12 (SDF1alpha)-CXCR4/CXCR7 pathway inhibition: an emerging sensitizer for anticancer therapies?   [0006] 
CXCR7 function as a scavenger for CXCL12 and CXCL11   [0006] 
CHEMICAL ABSTRACTS   [0009]  [0042] 
CHEMICAL ABSTRACTS   [0009]  [0042] 
Salt selection for basic drugs   [0015] 
Pharmaceutical Manufacturing   [0044] 
Tetrahedron Letters   [0067]  [0082]